
Sharp rise in airfare and food costs pushed UK inflation higher in July, denting rate cut hopes
The Office for National Statistics said consumer price inflation was 3.8% in the year to July, up from 3.6% in June. One of the contributors was airfares soaring by 30.2% between June and July, the biggest jump since the collection of monthly data began in 2001.
Most economists had anticipated a more modest rise in inflation to 3.7%.
With inflation now at its highest rate since January 2024 and nearly double the Bank of England's target of 2%, the prospects of another rate cut in 2025 are diminishing.
'July's outturn probably extinguishes hope of a September interest rate cut, while strengthening underlying inflationary pressures calls into question whether policymakers will be able to relax policy again this year," said Suren Thiru, economics director at the chartered accountants institute ICAEW.
The bank cut its main interest rate by a quarter of a percentage point to 4% earlier this month, its fifth reduction in a year, when policy makers began lowering borrowing costs from a 16-year high of 5.25%.
The Bank of England's key rate, a benchmark for mortgages as well as consumer and business loans, is now at the lowest level since March 2023.
The latest increase is another blow to the Labour government, which was partly propelled into power last July because of the cost-of-living crisis, which saw inflation rise to over 11% at one time.
Treasury chief Rachel Reeves acknowledged there was 'more to do to ease" the cost-of-living.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
6 minutes ago
- Reuters
China's Bio-Thera Solutions licenses its arthritis drug to Germany's STADA
HONG KONG, Aug 21 (Reuters) - China's Bio-Thera Solutions ( opens new tab said on Thursday it has granted Germany's STADA Arzneimittel commercialisation rights for its arthritis drug BAT1806, opens new tab in the EU, UK, Switzerland, certain Middle East and North Africa regions, and certain members of the Commonwealth of Independent States. Upfront payment and milestone payments will total up to 136 million euros ($158.34 million), including an 8.5 million euro down payment, milestone payments up to 127.5 million euros, and a double-digit percentage of net sales as revenue sharing, the Shanghai-listed firm said in a stock exchange filing, opens new tab. ($1 = 0.8589 euros)


Daily Mail
36 minutes ago
- Daily Mail
REVEALED: The forgotten clause that could now force Sir Jim Ratcliffe out of Man United - and what it means for the Glazers, Qataris and new owners
Last Wednesday, Manchester United crept back onto the market. It may well have passed by relatively unnoticed, but August 13 was a technically-significant date for the Premier League giants.


Reuters
36 minutes ago
- Reuters
China's Bio-Thera Solutions signs licensing deal with Germany's STADA for BAT1806 injection
HONG KONG, Aug 21 (Reuters) - China's Bio-Thera Solutions ( opens new tab on Thursday said it has signed an agreement granting Germany's STADA Arzneimittel commercialisation rights for its BAT1806 injection in the EU, UK, Switzerland, certain Middle East and North Africa regions, and certain members of the Commonwealth of Independent States. Upfront payment and milestone payments will total up to 136 million euros ($158.34 million), including an 8.5 million euro down payment, milestone payments up to 127.5 million euros, and a double-digit percentage of net sales as revenue sharing, the Shanghai-listed firm said in a stock exchange filing, opens new tab. ($1 = 0.8589 euros)